GANINI, CARLO
GANINI, CARLO
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification
2023-01-01 Rizzo, Mimma; Caliò, Anna; Brunelli, Matteo; Pezzicoli, Gaetano; Ganini, Carlo; Martignoni, Guido; Porta, Camillo Guglielmo Giuseppe
Despite an Abundance of Active Treatment Options for Renal Cell Carcinoma, Shadows Still Obscure the Light
2025-01-01 Porta, Camillo; Ganini, Carlo; Rizzo, Mimma
Il trattamento del carcinoma renale avanzato: un aggiornamento [The Treatment of Metastatic Renal Cell Carcinoma: An Update]
2023-01-01 Pezzicoli, Gaetano; Ganini, Carlo; Re Sartò, Giulia Vanessa; Pirovano, Marta; Cosmai, Laura; Porta, Camillo
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology
2024-01-01 Pirovano, Marta; Ganini, Carlo; Gallieni, Maurizio; Porta, Camillo; Cosmai, Laura
Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors
2025-01-01 Marrano, Nicola; Caporusso, Mariangela; Ganini, Carlo; Borraccino, Andrea; Cignarelli, Angelo; Perrini, Sebastio; Laviola, Luigi; Porta, Camillo; Giorgino, Francesco; Natalicchio, Annalisa
Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations
2024-01-01 Rizzo, Mimma; Pezzicoli, Gaetano; Ganini, Carlo; Carone, Luisa; Caliò, Anna; Brunelli, Matteo; Cosmai, Laura; Porta, Camillo
The future of cellular therapy for the treatment of renal cell carcinoma
2024-01-01 Chaoul, Nada; Lauricella, Eleonora; Giglio, Andrea; D'Angelo, Gabriella; Ganini, Carlo; Cives, Mauro; Porta, Camillo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification | 1-gen-2023 | Rizzo, Mimma; Caliò, Anna; Brunelli, Matteo; Pezzicoli, Gaetano; Ganini, Carlo; Martignoni, Guido; Porta, Camillo Guglielmo Giuseppe | |
| Despite an Abundance of Active Treatment Options for Renal Cell Carcinoma, Shadows Still Obscure the Light | 1-gen-2025 | Porta, Camillo; Ganini, Carlo; Rizzo, Mimma | |
| Il trattamento del carcinoma renale avanzato: un aggiornamento [The Treatment of Metastatic Renal Cell Carcinoma: An Update] | 1-gen-2023 | Pezzicoli, Gaetano; Ganini, Carlo; Re Sartò, Giulia Vanessa; Pirovano, Marta; Cosmai, Laura; Porta, Camillo | |
| Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology | 1-gen-2024 | Pirovano, Marta; Ganini, Carlo; Gallieni, Maurizio; Porta, Camillo; Cosmai, Laura | |
| Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors | 1-gen-2025 | Marrano, Nicola; Caporusso, Mariangela; Ganini, Carlo; Borraccino, Andrea; Cignarelli, Angelo; Perrini, Sebastio; Laviola, Luigi; Porta, Camillo; Giorgino, Francesco; Natalicchio, Annalisa | |
| Sarcoidosis-like reactions in metastatic renal cell carcinoma patients treated with immune-based combinations | 1-gen-2024 | Rizzo, Mimma; Pezzicoli, Gaetano; Ganini, Carlo; Carone, Luisa; Caliò, Anna; Brunelli, Matteo; Cosmai, Laura; Porta, Camillo | |
| The future of cellular therapy for the treatment of renal cell carcinoma | 1-gen-2024 | Chaoul, Nada; Lauricella, Eleonora; Giglio, Andrea; D'Angelo, Gabriella; Ganini, Carlo; Cives, Mauro; Porta, Camillo |